Abstract
Background: We hypothesized that the SKA2 gene can convert hemoglobin F to A leading to the maturity of the hematopoietic system by glucocorticoid hormone; so, the present study aimed to investigate the health outcome of newborns by using the effect of SKA2 gene on hematopoietic maturation.
Methods: At first, 142 samples were divided into term and preterm. After sampling from the umbilical cord blood, the expression of SKA2 genes and HbA and F were evaluated by quantitative RT-PCR. The blood gases were measured by Campact 3 device. Finally, the cortisol level was measured by ELISA method and HbA and F levels were investigated by capillary electrophoresis.
Results: The blood gases and Apgar scores were more favorable in term newborns (P <0.001). Levels of protein/expression of HbF in newborns with Apgar score greater than 7 was lower than that of the newborns with Apgar score below 7 (P <0.001). Cortisol and HbA levels were considerably higher in term newborns compared to the preterm ones (P <0.001). In the preterm and term groups, SKA2 gene expression had a positive and significant relationship with cortisol and HbA levels as well as a negative relationship with the HbF level. In the preterm group, a positive and significant relationship was observed between the expression of SKA2 and HbF genes.
Conclusion: The results revealed that the SKA2 gene affected hematopoietic maturation in preterm and term newborns and the health outcome of newborns improved by increasing HbA level.
Keywords: Cortisol, hemoglobin A, hemoglobin F, preterm infant, SKA2 gene
Graphical Abstract
[http://dx.doi.org/10.1097/AOG.0000000000000621] [PMID: 25569002]
[PMID: 25252091]
[http://dx.doi.org/10.1056/NEJMoa1516783] [PMID: 26842679]
[http://dx.doi.org/10.1093/ije/dyq029]
[http://dx.doi.org/10.1016/j.jgyn.2016.09.008] [PMID: 27776846]
[PMID: 24593889]
[http://dx.doi.org/10.1097/AOG.0000000000000748] [PMID: 26000510]
[http://dx.doi.org/10.1002/14651858.CD004454.pub3]
[http://dx.doi.org/10.1101/gad.13.22.2996] [PMID: 10580006]
[http://dx.doi.org/10.1186/1471-2393-15-S2-S3] [PMID: 26390927]
[http://dx.doi.org/10.1016/j.psyneuen.2016.10.005] [PMID: 27771566]
[http://dx.doi.org/10.1002/14651858.CD006764.pub3] [PMID: 23990333]
[http://dx.doi.org/10.1081/CBI-100101053] [PMID: 10841212]
[http://dx.doi.org/10.1016/j.fsi.2007.10.009] [PMID: 18065240]
[http://dx.doi.org/10.1093/rheumatology/kew348]
[http://dx.doi.org/10.1016/S0301-472X(02)00900-1] [PMID: 12384146]
[http://dx.doi.org/10.3389/fnmol.2012.00030] [PMID: 22448158]
[http://dx.doi.org/10.1182/blood.V39.5.688.688] [PMID: 5022717]
[http://dx.doi.org/10.1128/MCB.15.2.790] [PMID: 7529873]
[http://dx.doi.org/10.1159/000083634]
[http://dx.doi.org/10.1677/JOE-08-0019] [PMID: 18583474]
[http://dx.doi.org/10.1213/ANE.0000000000000705] [PMID: 25988638]
[http://dx.doi.org/10.1016/j.ejogrb.2019.04.013] [PMID: 31035118]
[PMID: 5450911]
[PMID: 29082763]
[http://dx.doi.org/10.1038/35049577] [PMID: 11262875]
[http://dx.doi.org/10.1182/blood-2014-12-570200]
[http://dx.doi.org/10.1203/00006450-197106000-00001]
[PMID: 6191270]
[http://dx.doi.org/10.1161/01.STR.6.6.707] [PMID: 1198637]
[http://dx.doi.org/10.1001/archneur.1971.00490010043006] [PMID: 5146409]
[http://dx.doi.org/10.1186/cc11389] [PMID: 23360555]
[http://dx.doi.org/10.1073/pnas.85.22.8540] [PMID: 2460870]
[http://dx.doi.org/10.1016/j.it.2010.02.002] [PMID: 20356793]
[http://dx.doi.org/10.1182/blood.V86.9.3353.bloodjournal8693353] [PMID: 7579438]
[http://dx.doi.org/10.1182/blood-2010-09-255679]
[http://dx.doi.org/10.1089/scd.2008.0032] [PMID: 18393628]
[http://dx.doi.org/10.1126/science.1066752] [PMID: 11799248]
[http://dx.doi.org/10.1182/blood-2005-08-3240] [PMID: 16380450]
[http://dx.doi.org/10.1038/sj.mp.4001735] [PMID: 16116489]
[http://dx.doi.org/10.1176/appi.ajp.2014.14010008] [PMID: 25073599]